A goal of this toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at any time: HIVToolkit@clintonhealthaccess.org.

Copyright © 2017

About CHAI

HIV Access Program 

Since its start in 2002, CHAI has been a leader in expanding access to HIV treatment, reducing the cost of drugs and diagnostics, and strengthening the capacity in high burden countries to combat HIV/AIDS. CHAI’s Access Program works to address barriers to commodity access and to foster a healthy marketplace, fundamentally changing the economics of global health to ensure the sustainable supply of essential medicines and diagnostics. By securing lower prices for key commodities and improving laboratories in the developing world, we are helping patients access the treatment and care they need. As a result of our portfolio of access program work, CHAI has an extensive network of staff with expertise in drug and diagnostics development, technology assessments, drug and diagnostics production, public health management, market dynamics and new product introduction, and government and civil society partnerships. 

CHAI Overview

Founded in 2002 by President William J. Clinton and Ira Magaziner, the Clinton Health Access Initiative (CHAI) is a global health organisation committed to strengthening integrated health systems around the world and expanding access to care and treatment for HIV/AIDS, malaria and other illnesses. Based on the premise that business oriented strategy can facilitate solutions to global health challenges, CHAI acts as a catalyst to mobilize new resources and optimize the impact of these resources to save lives, via improved organisation of commodity markets and more effective local management. By working in association with governments and other NGO partners, CHAI is focused on large scale impact and, to date, CHAI has secured lower pricing agreements for treatment options in more than 70 countries. In addition, CHAI's teams are working side-by-side with over 30 governments to tackle many of the largest barriers to effective treatment and care.